rs726217
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001008693.3(CST9):c.*31C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 1,608,140 control chromosomes in the GnomAD database, including 282,424 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 21513 hom., cov: 32)
Exomes 𝑓: 0.59 ( 260911 hom. )
Consequence
CST9
NM_001008693.3 3_prime_UTR
NM_001008693.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.435
Publications
22 publications found
Genes affected
CST9 (HGNC:13261): (cystatin 9) The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes a secreted protein that may play a role in hematopoietic differentiation or inflammation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.672 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CST9 | NM_001008693.3 | c.*31C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000376971.4 | NP_001008693.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CST9 | ENST00000376971.4 | c.*31C>T | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_001008693.3 | ENSP00000366170.4 |
Frequencies
GnomAD3 genomes AF: 0.494 AC: 75042AN: 151870Hom.: 21509 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
75042
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.585 AC: 140693AN: 240430 AF XY: 0.588 show subpopulations
GnomAD2 exomes
AF:
AC:
140693
AN:
240430
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.594 AC: 864270AN: 1456152Hom.: 260911 Cov.: 52 AF XY: 0.592 AC XY: 428782AN XY: 723798 show subpopulations
GnomAD4 exome
AF:
AC:
864270
AN:
1456152
Hom.:
Cov.:
52
AF XY:
AC XY:
428782
AN XY:
723798
show subpopulations
African (AFR)
AF:
AC:
5315
AN:
33382
American (AMR)
AF:
AC:
28516
AN:
43778
Ashkenazi Jewish (ASJ)
AF:
AC:
15815
AN:
25932
East Asian (EAS)
AF:
AC:
27441
AN:
39588
South Asian (SAS)
AF:
AC:
43692
AN:
85694
European-Finnish (FIN)
AF:
AC:
35096
AN:
53144
Middle Eastern (MID)
AF:
AC:
3699
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
669398
AN:
1108706
Other (OTH)
AF:
AC:
35298
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
18148
36296
54445
72593
90741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18096
36192
54288
72384
90480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.494 AC: 75054AN: 151988Hom.: 21513 Cov.: 32 AF XY: 0.501 AC XY: 37221AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
75054
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
37221
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
7398
AN:
41464
American (AMR)
AF:
AC:
9573
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
2119
AN:
3466
East Asian (EAS)
AF:
AC:
3540
AN:
5126
South Asian (SAS)
AF:
AC:
2359
AN:
4820
European-Finnish (FIN)
AF:
AC:
7049
AN:
10582
Middle Eastern (MID)
AF:
AC:
187
AN:
292
European-Non Finnish (NFE)
AF:
AC:
41096
AN:
67944
Other (OTH)
AF:
AC:
1105
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1655
3311
4966
6622
8277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1928
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.